Heron Therapeutics
HRTX
HRTX
151 hedge funds and large institutions have $192M invested in Heron Therapeutics in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 18 closing their positions.
Holders
151
Holders Change
+10
Holders Change %
+7.09%
% of All Funds
2.21%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
45
Reduced
38
Closed
18
Calls
$2.19M
Puts
$158K
Net Calls
+$2.04M
Net Calls Change
+$669K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$10.1M |
2 |
TC
2
Tejara Capital
London,
United Kingdom
|
$8.97M |
3 |
3
Renaissance Technologies
New York
|
$3.2M |
4 |
MAM
4
Monaco Asset Management
Monaco
|
$3.79M |
5 |
CPC
5
Congress Park Capital
Saratoga Springs,
New York
|
$3.06M |